Clinical Trial Update: Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Romiplostim (N01) for chemotherapy-induced thrombocytopenia in pediatric cancer patients; the study is currently not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Solid Tumors, Hematological Tumor | Phase 2 | Status: NOT_YET_RECRUITING